Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Latvia

Latvia: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and was 33.3% in 2021. ▼ Falling

Latest (2021)
33.3%
Change on year
up 8.8%
World rank
17th
of 185 countries
All-time high
41.7%
in 2005
All-time low
30.6%
in 2019
Years of data
22
2000–2021

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Latvia, 2000–2021

0102030402000201020212000: 40.1 %2001: 41.4 %2002: 41.4 %2003: 40.1 %2004: 40.5 %2005: 41.7 %2006: 41.6 %2007: 41.4 %2008: 39.7 %2009: 37.8 %2010: 37.6 %2011: 36.4 %2012: 35.2 %2013: 34.4 %2014: 34.1 %2015: 31.9 %2016: 32.1 %2017: 32.5 %2018: 31.8 %2019: 30.6 %2020: 30.6 %2021: 33.3 %

Source: World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO). Measured in %.

Analysis

Latvia recorded 33.3% for mortality from cvd, cancer, diabetes or crd between exact ages 30 and in 2021.

That represents a change of up 8.8% on the previous year and down 8.5% over ten years.

Over the whole period, mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Latvia peaked at 41.7% in 2005 and was at its lowest, 30.6%, in 2019.

Latvia ranks 17th of 185 countries on this measure, in the top 10%.

The long-run direction has been consistently falling across the 22 years of available data.

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Latvia, year by year

Annual values for Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%) in Latvia, 2000 to 2021.
Year % Change
2000 40.1%
2001 41.4% +3.2%
2002 41.4% +0.0%
2003 40.1% -3.1%
2004 40.5% +1.0%
2005 41.7% +3.0%
2006 41.6% -0.2%
2007 41.4% -0.5%
2008 39.7% -4.1%
2009 37.8% -4.8%
2010 37.6% -0.5%
2011 36.4% -3.2%
2012 35.2% -3.3%
2013 34.4% -2.3%
2014 34.1% -0.9%
2015 31.9% -6.5%
2016 32.1% +0.6%
2017 32.5% +1.2%
2018 31.8% -2.2%
2019 30.6% -3.8%
2020 30.6% +0.0%
2021 33.3% +8.8%

Latvia compared with similar countries

  • Latvia's 33.3% is above the median for high income countries, which is 13.1%, 2.6× the median. (58 countries reporting)
  • Latvia's 33.3% is above the median for Europe & Central Asia, which is 20.4%, 1.6× the median. (48 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2000s 40.6% 37.8% 41.7% 10
2010s 33.7% 30.6% 37.6% 10
2020s 31.9% 30.6% 33.3% 2

Countries ranked near Latvia

  1. 14 Mongolia 33.9% compare
  2. 15 Bulgaria 33.8% compare
  3. 16 Mozambique 33.5% compare
  4. 18 Georgia 32.9% compare
  5. 19 Russian Federation 31.8% compare
  6. 20 Afghanistan 31.5% compare

See the full ranking of 232 places →

More health data for Latvia

All data for Latvia →

Frequently asked questions

What is mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Latvia?
Mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Latvia was 33.3% in 2021, according to World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO).
What is the highest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in Latvia?
The highest recorded value was 41.7% in 2005.
What is the lowest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in Latvia?
The lowest recorded value was 30.6% in 2019.
How does Latvia rank for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
Latvia ranks 17th out of 185 countries with data for 2021.
Is mortality from cvd, cancer, diabetes or crd between exact ages 30 and rising or falling in Latvia?
Over the last ten years it is down 8.5%. The long-run trend across the full record is falling.
Where does this Latvia data come from?
The figures come from World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as part of Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 22 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Latvia. Statizoid, drawing on World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO). Retrieved 14 September 2026, from https://health.statizoid.com/stat/mortality-from-cvd-cancer-diabetes-or-crd-between-exact-ages-30-and-70-male-percent/latvia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/mortality-from-cvd-cancer-diabetes-or-crd-between-exact-ages-30-and-70-male-percent/latvia/">Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Latvia</a> — Statizoid

About this data

Indicator
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%)
Unit
%
Source
World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
232 places, 5,104 data points, 2000–2021
Last refreshed

Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).